Abstract

IntroductionTuberculosis (TB) is a leading cause of morbidity and mortality in South Africa. Clinical parameters are important objective outcomes in TB; however they often are not directly correlated with subjective well-being of the patient, but can be assessed using patient-reported outcome (PRO) measures. Health-related quality of life (HRQOL) is a specific PRO generally multi-dimensional in nature and includes physical, mental and social health domains. The inclusion of HRQOL PROs in trials and clinical practice can provide additional information beyondclinical and microbiological parameters. Furthermore, HRQOL may be associated with medication adherence. This review focuses on patient-reported HRQOL and its association with medication adherence in TB patients in South Africa.MethodsA comprehensive search strategy was developed focusing on the impact of TB on patient-reported HRQOL,the existence of a conceptual framework of TB-specific HRQOL, determinants of medication adherence and the association of HRQOL with medication adherence. Data were extracted from all identified articles and additionaldata extraction was performed by two independent reviewers with special focus on longitudinal studies in order to understand changes of HRQOL and adherence over time. Research gaps were identified with regard to patient-reported HRQOL and medication adherence.ResultsA total of 66 articles met the eligibility criteria. Ten HRQOL studies and one adherence study used a longitudinal design, none of these in South Africa. A variety of different generic and disease-specific HRQOL measures were identified in the articles. In South Africa four HRQOL and five adherence studies (non-longitudinal) were published. Similar factors (socio-demographic, socio-economic, disease-related, therapy-related and psycho-social aspects) affect HRQOL and adherence. Although standard TB treatment improved all health domains, psychological well-being and social functioning remained impaired in microbiologically cured patients after treatment.ConclusionWhile evidence of TB impact on HRQOL and medication adherence and their association exists, it is verylimited for the South African situation. No valid and reliable TB-specific HRQOL measures were identified in this systematicreview. An assessment of HRQOL in TB patients in South Africa is required as this may assist with improving current disease management programmes, medication adherence and national treatment guidelines.Electronic supplementary materialThe online version of this article (doi:10.1186/s12955-016-0442-6) contains supplementary material, which is available to authorized users.

Highlights

  • Tuberculosis (TB) is a leading cause of morbidity and mortality in South Africa

  • The relevance and importance of Health-related quality of life (HRQOL) assessments is growing and HRQOL has become an important tool for the understanding of health outcomes adopting a patient-centred approach to care and treatment

  • Further research is required in a country-specific context to contribute to efficient decision making with regard to TB related strategies; product approval, pricing and reimbursement as well as health policy making; A number of new anti-TB drugs, vaccines and diagnostics have recently achieved marketing approval or are in late clinical development.Assessment of longitudinal changes in HRQOL and its association to medication adherence in TB in a high TB burden country such as South Africa are not yet available

Read more

Summary

Introduction

Tuberculosis (TB) is a leading cause of morbidity and mortality in South Africa. The inclusion of HRQOL PROs in trials and clinical practice can provide additional information beyondclinical and microbiological parameters. HRQOL may be associated with medication adherence. This review focuses on patient-reported HRQOL and its association with medication adherence in TB patients in South Africa. Despite the availability and affordability of effective TB medication South Africa has the highest prevalence and incidence rates (696 and 834 cases per 100,000 population) among these countries [1] TB is South Africa’s leading cause of mortality (134 cases per 100,000 population). TB is known to impact health-related quality of life (HRQOL) [2–4]. The assessment of an association between both, HRQOL and medication adherence in TB, would provide valuable information on treatment effectiveness, optimal disease management and health policy making

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call